Clinical Trial Update: Pilot Study to Assess Efficacy and Safety of Treamid in the Rehabilitation of Patients After COVID-19 Pneumonia [Phase 2]

View source ↗

Summary

Phase 2 pilot study evaluating efficacy and safety of Treamid for rehabilitation after COVID-19 pneumonia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Fibrosis

Drugs mentioned

• Treamid

Snippet

Sponsor: PHARMENTERPRISES LLC | Conditions: SARS-CoV-2 Infection, Fibrosis Lung | Phase 2 | Status: COMPLETED